HKSE - Delayed Quote HKD
HighTide Therapeutics, Inc. (2511.HK)
1.720
+0.050
+(2.99%)
As of 11:57:36 AM GMT+8. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 273.98M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Liu (Liping Ph.D.) Chief Executive Officer | -- | Direct | -- | Apr 1, 2025 |
| Ma (Lixiong) Director (Non-Executive) | -- | Direct | -- | Apr 1, 2025 |
| Yu (Meng) Director (Executive) | -- | Direct | -- | Apr 1, 2025 |
| Zhu (Xun) Director (Non-Executive) | -- | Direct | -- | Apr 1, 2025 |
| Liu (Liping Ph.D.) Chief Executive Officer | -- | Direct | -- | Jan 1, 2025 |
| Yu (Meng) Director (Executive) | -- | Direct | -- | Jan 1, 2025 |
| Zhu (Xun) Director (Non-Executive) | -- | Direct | -- | Jan 1, 2025 |
| Liu (Liping Ph.D.) Chief Executive Officer | -- | Direct | -- | Dec 31, 2024 |
| Ma (Lixiong) Director (Non-Executive) | -- | Direct | -- | Dec 31, 2024 |
| Ma (Lixiong) Director (Non-Executive) | -- | Direct | -- | Dec 22, 2024 |
| Yu (Meng) Director (Executive) | -- | Direct | -- | Dec 22, 2024 |
| Liu (Liping Ph.D.) Chief Executive Officer | -- | Direct | -- | Apr 1, 2024 |
| Ma (Lixiong) Director (Non-Executive) | -- | Direct | -- | Apr 1, 2024 |
| Yu (Meng) Director (Executive) | -- | Direct | -- | Apr 1, 2024 |
| Zhu (Xun) Director (Non-Executive) | -- | Direct | -- | Apr 1, 2024 |
| Liu (Liping Ph.D.) Chief Executive Officer | -- | Direct | -- | Dec 31, 2023 |
| Ma (Lixiong) Director (Non-Executive) | -- | Direct | -- | Dec 31, 2023 |
| Yu (Meng) Director (Executive) | -- | Direct | -- | Dec 31, 2023 |
| Zhu (Xun) Director (Non-Executive) | -- | Direct | -- | Dec 31, 2023 |
Related Tickers
2137.HK Brii Biosciences Limited
1.760
-3.30%
6628.HK Transcenta Holding Limited
1.260
-0.79%
9606.HK Duality Biotherapeutics, Inc.
216.400
-1.01%
INTS Intensity Therapeutics, Inc.
1.3000
-28.18%
APLM Apollomics, Inc.
6.19
+7.47%
CGEM Cullinan Therapeutics, Inc.
8.38
+0.12%
KALV KalVista Pharmaceuticals, Inc.
12.45
+1.22%
VRDN Viridian Therapeutics, Inc.
13.51
-1.82%
APM Aptorum Group Limited
0.9601
+6.80%
ELEV Elevation Oncology, Inc.
0.3788
+1.83%